#MEDIA: Announcing positive topline results from the Phase 3 ACTION-1 trial of an investigational @RayzeBio therapy in people with GEP-NETs, a rare and difficult-to-treat cancer. An important step forward for patients with limited treatment options.
We work every day to transform patients’ lives through science. See our community guidelines: one.bms.com/3WHdbIG

